Skip Navigation


British Medical Bulletin Advance Access originally published online on August 29, 2008
British Medical Bulletin 2008 87(1):175-192; doi:10.1093/bmb/ldn032
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
87/1/175    most recent
ldn032v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bailey, A. C.
Right arrow Articles by Fisher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bailey, A. C.
Right arrow Articles by Fisher, M.
Related Collections
Right arrow HIV/AIDS
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Current use of antiretroviral treatment

A. C. Bailey* and M. Fisher

Department of Sexual Health and HIV, Brighton and Sussex University Hospitals NHS Trust, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK

* Correspondence to: Dr Angela Bailey, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK. E-mail: angebailey{at}doctors.org.uk

Introduction: Antiretroviral therapy for HIV infection has transformed it from a terminal illness to a chronic manageable condition. This review summarizes the history of the treatment and explains the current practice in the field, including uses in prevention strategies.

Sources of data: National and international guidelines, important publications in peer reviewed literature and recent important conference abstracts.

Areas of agreement: There is a broad agreement on the choice of drug regimens and on the need to treat patients with symptomatic HIV infection and with CD4 cell counts less than 350 cells/mm3. The need to adapt therapy to individual circumstances is also well accepted, e.g. hepatitis co-infection and pregnancy.

Areas of controversy: Treatment of acute HIV infection and the optimum time to commence therapy in asymptomatic chronic infection remain controversial. Use of antiretrovirals for prevention, e.g. pre-exposure and post-exposure prophylaxis, is still developing.

Growing points: This article summarizes the current use of anti-HIV medication and the evidence behind it for the non-specialist.

Areas timely for developing research: New strategies for using current drugs, the best use of newly available drugs and new uses of antiretroviral drugs, such as in prevention of HIV transmission, are key areas for research. Further research addressing the question of when to start antiretrovirals and assessing their long-term effects is also needed.

Keywords: HIV • antiretroviral therapy • prevention • hepatitis co-infection • opportunistic infections

Accepted for publication August 5, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.